INCLINE THERAPEUTICS, INC.

Profile

Company Names

INCLINE THERAPEUTICS, INC.

Addresses

900 SAGINAW DRIVE, SUITE 200, REDWOOD CITY, CA 94063

601 UNION STREET, TWO UNION SQUARE, SUITE 3200, SEATTLE, WA 98101

601 UNION, TWO UNION SQUARE, SUITE 3200, SEATTLE, WA 98101

Phone Numbers

(650) 241-6800
(206) 621-7200

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$43,940,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2011-09-13 
$21,500,000.00 
$21,500,000.00 
$0.00 
Equity 
2
2010-06-21 
$22,000,000.00 
$43,500,000.00 
$21,500,000.00 
Equity 
1
2009-12-23 
$440,000.00 
$440,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JIM 
 
GLASHEEN 
DIRECTOR
TRANSCEND MEDICAL INC   |  REVANCE THERAPEUTICS, INC.   |  INCLINE THERAPEUTICS, INC.   |  ELCELYX THERAPEUTICS, INC.   |  FORSIGHT VISION5, INC.   |  CLADE THERAPEUTICS, INC.
JAMES 
 
GLASHEEN, PH.D. 
DIRECTOR
INCLINE THERAPEUTICS, INC.
TERRY 
 
GOULD 
DIRECTOR
NEURALTUS PHARMACEUTICALS, INC.   |  PROTEUS BIOMEDICAL INC   |  LIGHT SCIENCES ONCOLOGY INC   |  INCLINE THERAPEUTICS, INC.   |  NAUREX INC.   |  ONCOMED PHARMACEUTICALS INC   |  OUTPOST MEDICINE, LLC   |  ATOX BIO INC.   |  QPEX BIOPHARMA, INC.   |  ICOSAVAX, INC.
ALAN 
 
LEVY, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
INCLINE THERAPEUTICS, INC.   |  CHRONO THERAPEUTICS INC.
THEODORE 
R. 
SCHROEDER 
DIRECTOR
INCLINE THERAPEUTICS, INC.   |  TRIUS THERAPEUTICS INC   |  SG PHARMACEUTICALS, INC.   |  ZAVANTE THERAPEUTICS, INC.   |  CIDARA THERAPEUTICS, INC.
DAVID 
 
SOCKS 
EXECUTIVE OFFICER
INCLINE THERAPEUTICS, INC.   |  NEXCIDA THERAPEUTICS, INC.   |  RECIDA THERAPEUTICS, INC.   |  ELEUSIS HOLDINGS LTD
DAVID 
A. 
SOCKS 
EXECUTIVE OFFICER
INCLINE THERAPEUTICS, INC.
JAMES 
 
TOPPER 
DIRECTOR
CALISTOGA PHARMACEUTICALS INC   |  INCLINE THERAPEUTICS, INC.   |  PORTOLA PHARMACEUTICALS INC   |  ATTEROCOR, INC.   |  SEMNUR PHARMACEUTICALS, INC.   |  PRONAI THERAPEUTICS INC   |  ALLENA PHARMACEUTICALS, INC.   |  CHANRX CORP.   |  ANAPTYSBIO INC   |  LAGUNA PHARMACEUTICALS, INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  MERGANSER BIOTECH, INC.   |  ALCRESTA, INC.   |  ALCRESTA THERAPEUTICS, INC.   |  MILLENDO THERAPEUTICS, INC.   |  APTINYX INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  ENLAZA THERAPEUTICS, INC.
JAMES 
 
TOPPER, M.D., PH.D. 
DIRECTOR
INCLINE THERAPEUTICS, INC.
JIM 
 
YOUNG 
DIRECTOR
INCLINE THERAPEUTICS, INC.   |  PORTAL INSTRUMENTS, INC.   |  IMPEL NEUROPHARMA INC   |  CHEATHAM STREET, LP   |  CANNAROYALTY CORP.   |  ELMIRA JV, LLC   |  SH127 LLC   |  SH-46 LLC   |  SH100, LLC   |  TL 99 LLC   |  SABOT DROPZONE LLC   |  SABOT SEGUIN ONE, LLC   |  ROCKPORT LANDING INVESTOR, LLC   |  M34 CAPITAL OPPORTUNITY FUND I, L.P.
JAMES 
W. 
YOUNG, PH.D. 
DIRECTOR
INCLINE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-09-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-09-13 
2010-06-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-21 
2010-01-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-12-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#